Neobiotech Hosts Business Seminar for Eastern Europe, Caucasus, and Central Asia
Neobiotech invited dentists from various countries abroad and hosted a seminar in Korea.
The seminar, which took place over a 5-night, 6-day period, was attended by over 70 dentists from a total of six countries, including Poland, Lithuania, Czech Republic, Moldova, Azerbaijan, and Kyrgyzstan. During this event, participants had the opportunity to share in Neo's unique technology and know-how in using the product.
As the first part of the event, the participants visited the GAO office in Cheongdam-dong, Seoul. There, they attended a lecture and hands-on practice session on the topic "Practical clinical applications of the CMI concept, when to apply functional stress after implant surgery?" conducted by Dr. Young-Ku Heo and Professor Seong-Bok Lee.
Professor Lee Seong-Bok lectured on topics such as ▲ CMI concept for Anytime loading ▲ the latest approaches to computer-guided surgery and clinical practices. Dr. Young-Ku Heo conducted hands-on practice sessions on the topic of ▲ computer-guided implant surgery ▲ minimally invasive upper jaw sinus lift surgery ▲ safe bone grafting for challenging alveolar bone.
After completing the schedule at the GAO office, the participants moved to Wonju, Gangwon Province, where Neobiotech's headquarters is located, to finish the remaining itinerary. They visited Neo's implant production and research facilities, business departments, etc., providing them with an opportunity to directly observe the production process of Neobiotech products.
Afterwards, they had the opportunity to experience the emotions and culture of Korea through visits to Korean cultural heritage sites.
A Neobiotech official said, "This seminar provided an opportunity to validate the positive feedback from overseas users regarding Neobiotech products. we will continue to consistently create opportunities to introduce Neobiotech to international users and maintain ongoing communication."
Neobiotech currently supplies implants to more than 70 countries, including the United States, Japan, Europe, Russia, and Thailand. It has been proving to be stable based on excellent quality, elevating its status as a global implant company in the market.